Free express worldwide shipping10% off · first order

EVLOmd · June 2026

Prepared by Aira. Analysis of five direct competitors. Educational notes for the team. Not medical advice.

EVLOmd — Competitive Intelligence Report

Prepared by Aira  ·  June 2026  ·  Analysis of 5 direct competitors

Lifeforce
mylifeforce.com  ·  Founded 2021  ·  Backed by Tony Robbins, Peter Diamandis, Serena Williams
$349 setup + $149/mo

What they do well

Premium longevity brand with celebrity founders — massive credibility and trust
50+ biomarker testing with at-home phlebotomist blood draw — very convenient
Quarterly retesting included — tracks progress over time
85% of members report better quality of life in 3 months — strong social proof
Physician-guided plans with dedicated health coach access

Weaknesses

100% digital — no human warmth, no personal relationship with Rob-style founders
$149/month is expensive for mass market — limits client base to upper income
No peptide protocols — focuses on biomarkers and supplements only
No community — members never connect with each other
Coach access feels like email/text support, not dedicated 1-on-1 relationship

What is missing from their customer experience

There is no real human relationship. You get data, a dashboard, and a health coach you can text. But nobody is personally invested in your transformation. The experience feels like a software product, not a health partner. There is also zero peptide therapy — the fastest-growing category in performance optimization.

How EVLOmd wins against Lifeforce

Rob's personal relationship with every client is the differentiator Lifeforce can never replicate at scale. Clients get Rob — not a dashboard. Add peptide protocols on top of biomarker optimization and EVLOmd becomes the more complete solution at a comparable or better price point. The switch happens when someone realizes they want transformation, not just tracking.

Superpower
superpower.com  ·  Launched publicly April 2025  ·  $30M Series A  ·  150k+ waitlist
$199/year

What they do well

Best branding and UX in the space — the product feels premium and modern
$199/year price point made biomarker testing accessible to the mass market
100+ biomarker panel including biological age tracking — best data depth
24/7 SMS access to medical team — fast response, high perceived value
Viral launch with compelling founder story — strong word of mouth growth

Weaknesses

Currently facing a federal lawsuit from Function Health over alleged biomarker count inflation — reputational risk
AI concierge routinely recommends $400/month supplement stacks — feels predatory
No mobile app in 2025 — critical miss for a daily health product
No peptides, no hormone protocols, no actual treatment — just data and recommendations
Wearable integration broken — Apple Health not supported, Oura data unused

What is missing from their customer experience

Superpower gives you an incredible amount of information and then essentially leaves you alone to figure out what to do with it. The AI recommends supplements but does not actually implement a protocol. There is no physician prescribing actual treatments. It is data without execution — which is exactly what EVLOmd executes on.

How EVLOmd wins against Superpower

Superpower sells insights. EVLOmd sells results. When a Superpower member gets their data back and realizes they need hormone optimization and peptide therapy to actually fix what the data shows — that is the EVLOmd conversion moment. Target Superpower users who are frustrated that their data pointed to a problem but nobody prescribed a solution.

Function Health
functionhealth.com  ·  Co-founded by Dr. Mark Hyman  ·  $100M+ revenue
$499/year

What they do well

160+ lab tests — most comprehensive panel in the market
Dr. Mark Hyman credibility — trusted name in functional medicine
Strong brand awareness — largest player in direct-to-consumer lab testing
Simple onboarding and clean dashboard — easy to understand results

Weaknesses

Labs are the entire product — no treatment, no prescriptions, no peptides
Customer service is broken — AI chatbots only, zero live agents, major complaints
One-time testing model — clients get data then disappear, no continuity
Currently suing Superpower — distracted leadership, negative press attention

What is missing from their customer experience

Function tells you what is wrong but does not fix it. Customers leave with results, recommendations, and zero follow-through. The biggest complaint across hundreds of reviews is "I have the data but I do not know what to do next." There is no human holding their hand through implementation. No real doctor relationship. Just a dashboard and a generic action plan.

How EVLOmd turns a one-time lab purchase into a lifelong relationship

Run the labs. Then prescribe the protocol. Then execute the peptide and hormone optimization. Then retest. Then adjust. Function stops at step one. EVLOmd is steps two through ten. The EVLOmd pitch to a Function Health user: "You already know what's wrong. Now let us actually fix it."

Fountain Life
fountainlife.com  ·  Co-founded by Peter Diamandis  ·  Executive longevity positioning
$25,000+/year

What they do well

Most advanced screening available — full body MRI, CT scans, AI-driven analysis
Executive-level positioning — the go-to for billionaires and C-suite longevity
Peter Diamandis credibility is unmatched in the longevity space
Fully white-glove — every client gets deep personal attention

Weaknesses

$25,000+ per year pricing eliminates 99% of the market — not accessible
Physical locations required — not scalable nationally or internationally
Too complex — most clients do not need full body MRI to start optimizing
No entry-level offering — you are either in at $25k or you are out

What is missing from their customer experience

Fountain Life is for the 0.1%. The middle tier — high performers who earn $150k to $500k per year and want elite health optimization but cannot spend $25,000 — is completely underserved. That is the EVLOmd client. Aspirational but accessible.

How EVLOmd delivers 80% of the value at a fraction of the cost

The core of what Fountain Life does — optimize hormones, prescribe peptides, run advanced labs, track results — can be delivered for $2,500 to $3,000 per client. EVLOmd is the Fountain Life for people who are not yet billionaires but are building toward it. That is a massive underserved market. Position explicitly: "Elite optimization. Without the $25,000 price tag."

Ways2Well
ways2well.com  ·  Hormones, peptides, functional medicine  ·  Clinic-centric model
$300+ per protocol

What they do well

Actually prescribes peptides and hormones — the closest competitor to EVLOmd's actual product
Functional medicine approach — treats root cause, not just symptoms
Lab-driven protocols — data informs treatment decisions

Weaknesses

Terrible customer experience — real Trustpilot complaints about $300 peptides shipped with no instructions, left in Texas sun, rendered unusable
Staff not knowledgeable — one complaint states advisor unfamiliar with widely-used peptides
Clinic-centric — requires physical location visits, limits scalability
No data platform — no dashboard, no tracking, no ongoing optimization system

What is missing from their customer experience

Ways2Well sells treatments but not a system. Clients get peptides shipped to them with no education, no follow-up, and no accountability. The product experience is broken enough that real customers are publicly warning others not to use them. This is the clearest example of what EVLOmd should never become — and also the biggest opportunity to steal their unhappy clients directly.

How EVLOmd becomes a health operating system instead of just a clinic

Ways2Well is a transaction. EVLOmd is a relationship. Every client gets a personal onboarding call with Rob, a customized protocol, education on exactly how to use their peptides, weekly check-ins, and a 30-day reorder system that never lets them fall off. The EVLOmd pitch to a Ways2Well client: "You deserve better than a package arriving with no instructions."

The EVLOmd winning thesis

Every competitor sells one piece. EVLOmd sells the whole system.

Test
Labs that actually matter for hormone and peptide optimization — not just biomarker data for data's sake
Interpret
Rob personally explains what the results mean and what protocol fits — not an AI chatbot, not a generic action plan
Optimize
Physician-supervised peptide protocol prescribed and shipped — the thing no competitor actually does well
Retest
30-day reorder cycle with check-ins — clients are never left wondering if it is working
Improve
Protocol adjusted based on results — this is the lifelong relationship competitors cannot build at scale
Repeat
Membership model that compounds — clients who see results refer two more clients

What would make EVLOmd impossible to ignore

Copy from competitors
Lifeforce's quarterly retest model. Superpower's clean dashboard UX. Function's comprehensive lab panel. Fountain Life's premium positioning.
Avoid from competitors
Function's AI-only support. Ways2Well's zero client education. Superpower's supplement upsell trap. Fountain Life's inaccessible pricing.
Opportunities nobody is taking
Personal founder relationship at scale. Peptide education content that builds trust before the sale. Community of clients who share results. Entry-level offer that converts to high-ticket.
The clear switching moment
When a competitor client has data but no solution. When they get bad service. When they feel like a number. Rob's personal attention at that moment = conversion.

Research and educational context only. Nothing in this report is medical advice, and no protocol described here is an offer to diagnose, treat, cure, or prevent any condition.